Develops blood-based biomarker tests for preterm birth.
Jun 2026Revenue $70.0K/yrExpenses $37.4M/yr
No trendCash runway ≈ 1.7 years from Jun 2026
Figures by year
When will Sera Prognostics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $70.0K and expenses $37.4M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $81.0K | $36.6M | −$36.5M |
| Dec 2024 | $77.0K | $36.7M | −$36.6M |
| Dec 2023 | $306K | $40.1M | −$39.8M |
| Dec 2022 | $268K | $45.9M | −$45.7M |
| Dec 2021 | $82.0K | $35.5M | −$35.4M |
| Dec 2020 | $25.0K | $18.0M | −$18.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.